Prop 61: Californians appear to say no to lowering drug costs
From the article:
Rachel Sachs, a law professor who studies health policy at Washington University in St. Louis, cautioned against interpreting the ballot measure’s failure as a public repudiation of anything other the specific initiative.
“It’s tough to say that a ‘No’ vote means that there is no more problem, or that consumers aren’t still angry at the pharmaceutical industry,” Sachs said. “It just means that at this time this is not the way to move forward on drug pricing.”
Read the full article.fellowship health law policy rachel sachs